about
Discovery and validation of new potential biomarkers for early detection of colon cancerA transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasisIdentification of candidate susceptibility genes for colorectal cancer through eQTL analysis.A 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer.Large differences in global transcriptional regulatory programs of normal and tumor colon cellsClinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumorsAltered pathways and colorectal cancer prognosisGene expression differences between colon and rectum tumorsExome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal CancerAlgorithmic methods to infer the evolutionary trajectories in cancer progression.Mutanome and expression of immune response genes in microsatellite stable colon cancerTools for protein-protein interaction network analysis in cancer research.Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.Molecular monitoring of epithelial-to-mesenchymal transition in breast cancer cells by means of Raman spectroscopy.Molecular approaches for classifying endometrial carcinoma.Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs.Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer.Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information.A taxonomy of organ-specific breast cancer metastases based on a protein-protein interaction network.Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling.RET-fusions: a novel paradigm in colorectal cancer.Colon-specific eQTL analysis to inform on functional SNPsComprehensive molecular characterisation of hereditary non-polyposis colorectal tumours with mismatch repair proficiencyAbstract C16: Serological biomarkers reflecting collagen remodeling of the tumor microenvironment are elevated in metastatic colorectal cancer patientsGRP94 protein and prosurvival autophagy, the Achilles heel on brain metastasis progressionAre Gene Signatures Ready for Use in the Selection of Patients for Adjuvant Treatment?AMER1 Is a Frequently Mutated Gene in Colorectal Cancer--LetterAlgorithmic Methods to Infer the Evolutionary Trajectories in Cancer ProgressionAbstract 2396: Hampering the crosstalk between fibroblasts and tumor cells reveals the need for blocking both canonical and non-canonical TGFβ pathwaysIntrinsic cancer subtypes-next steps into personalized medicineUnsupervised analyses reveal molecular subtypes associated to prognosis and response to therapy in colorectal cancerUnderstanding Cancer Progression Using Protein Interaction NetworksNon-canonical TGFb pathway relieves the blockade of IL-1b/TGFb-mediated crosstalk between tumour and stroma: TGFBR1TAK1 inhibition in colorectal cancerTelomere length alterations in microsatellite stable colorectal cancer and association with the immune responseAnalysis of Killer Immunoglobulin-Like Receptor Genes in Colorectal CancerGRP94 promotes brain metastasis by engaging pro-survival autophagy.T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E MelanomaColorectal cancer: A paradigmatic model for cancer immunology and immunotherapy
P50
Q21131953-26E66642-18A8-421B-B9C0-ADFCAE11C09AQ28289791-A7FB6A8A-E682-4AB7-84AF-8B9E3DCCAD3BQ34096808-47D1E228-AB4C-4B35-A986-A2E8E76AD54CQ34227755-6D495FDD-D549-4D66-9BD4-19C3119D364DQ34278484-E46F4BDC-A184-410C-BE9E-45D8550AEEBCQ34473636-3980F831-2F8A-47A8-B822-07BBD5157184Q34479613-F6504A6A-D774-4C1A-A160-A2FCF6568E34Q35168104-DA69839A-EF6B-43CC-87FD-76A4912780CDQ35313181-580D524E-EAA8-43A1-9BDE-E3406D936357Q35589710-FC1AE0F5-469D-4D55-A8C2-922BDDAD466DQ36172515-301710FB-4A96-4BB8-9448-5B9F46EDFAC9Q37102361-52325817-AF66-4314-8224-A6B4F7F6CF04Q37109573-FD4BE8C9-AC4F-481D-9BC0-522770D93A23Q37977413-9B06D957-F52C-4D38-BFC4-DB415ACE9BBBQ38690817-3881F2C5-2171-4F76-A5AD-8EDDFBF2A4EBQ39002748-15340B8A-1BFE-407B-BBBE-03EC2FDB4DE3Q39063614-AB5BB3FD-094A-4489-8A6F-5457E15BF02EQ39376892-39DA09C0-6D8B-4CF9-A584-FF0A2CDBA833Q39682144-7FFEDDFE-6EA0-46A7-BEE5-BC82DC14F6D3Q41135217-154F0DA1-971B-4E98-901A-9EAC8FF19C39Q43551742-BEF2F884-CA19-4615-AFD9-E7A534BA9D46Q47801747-12C1A0CC-F73D-430F-959D-DFB297631EB6Q52592183-C6DEF55F-49CD-4A16-A1FC-F0AE26D09C44Q57025029-8A7F1A5A-C8DA-4084-AE99-7CC213F88BDDQ57742610-C63700A5-46FD-4A6C-B297-37AD3786A08DQ58053516-A232BDE8-A098-458D-9869-916B2E4ECCC1Q58053519-B1F04DBD-C100-44C2-9188-A424A7BDF892Q58053523-1D54945F-7C81-4105-802B-C97A43702C55Q58053526-15D5D69C-A968-4536-A890-89C2833B30D6Q58053528-89B69187-D5DC-4AA9-A620-58620BE64F32Q58053531-503221A9-632C-4F0C-89B6-02B5B6AD39E6Q58053534-D5B94131-08D7-445D-A7D7-D142D947A6A3Q58053541-90E6646E-984C-44C7-A058-92F7E5720EC6Q58053547-67980DA4-C813-4355-9438-C42CCD1EA0FDQ64111232-B6FF0E86-45B1-439A-96BD-25FBD2A5AE9DQ89122984-E39F9F16-42F9-40D9-974D-E702D6103A6FQ89896458-452FD9BA-4F76-4B32-951B-5049549719E4Q90829737-78AFDA1C-3B23-460E-B5B9-7AE988079BF0Q92253133-1D534580-DBCB-4514-B06A-65BC52C07802Q92343939-E21BE08F-57E3-4FEB-852A-AE3448E79B2C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rebeca Sanz-Pamplona
@ast
Rebeca Sanz-Pamplona
@en
Rebeca Sanz-Pamplona
@es
Rebeca Sanz-Pamplona
@nl
type
label
Rebeca Sanz-Pamplona
@ast
Rebeca Sanz-Pamplona
@en
Rebeca Sanz-Pamplona
@es
Rebeca Sanz-Pamplona
@nl
prefLabel
Rebeca Sanz-Pamplona
@ast
Rebeca Sanz-Pamplona
@en
Rebeca Sanz-Pamplona
@es
Rebeca Sanz-Pamplona
@nl
P106
P31
P496
0000-0002-2187-3527